Navigation Links
Study Gets Closer to Origins of Leukemia
Date:1/17/2008

Targeting a mutated cell might bring better treatments, researchers say

THURSDAY, Jan. 17 (HealthDay News) -- By studying blood cells in a young pair of twins, scientists say they're gaining new insight into how some children are poised to develop leukemia even before birth.

The researchers report in a new study that both twins -- one who developed leukemia and one who didn't -- shared cells that mutated and became precancerous. In one of the twins, the cancer-ready cells developed enough mutations to sicken the child.

The findings are a "first look at the earliest events in the process that ultimately leads to leukemia," said study co-author Tariq Enver, a professor at John Radcliffe Hospital in Oxford, England.

According to Enver, the next step is to figure out how to use this knowledge to help scientists do a better job of targeting specific leukemia cells with "smart" drugs.

Leukemias can affect both children and adults. An estimated 44,240 cases of the disease were diagnosed in the United States in 2007, according to The Leukemia & Lymphoma Society.

Fortunately, the death rate from leukemia for children has fallen drastically over the past 30 years, although several hundred still die of the disease in the United States each year. The society estimates that 21,790 Americans died of the disease in 2007.

In the new study, published in the Jan. 18 issue of the journal Science, Enver and colleagues in the United Kingdom, Japan and Italy looked at cells in the blood of identical female twins. One developed leukemia at the age of 2, while the other remained healthy.

At issue: Before birth, did the twins share a certain type of cell that became cancerous in one twin but not in the other? The answer, the study found, is yes.

According to Enver, both twins ended up with precancerous cells, which they shared in the uterus by both getting blood from the same placenta. Somehow, further mutations made the precancerous cells become cancerous in the twin who became ill.

Dr. Bart Kamen, chief medical officer of The Leukemia & Lymphoma Society, lauded the study as a "remarkable paper" that provides a new perspective on how leukemia develops. Essentially, he said, the study suggests that the precancerous cells don't always cause cancer but can do so under a specific condition -- that is, if they mutate beyond the initial aberration that made them dangerous in the first place.

As for the implications for treatment, the research suggests that "even if we killed the leukemia by killing the cells that are malignant, this one [cell type] might still be there. Maybe we didn't kill it," Kamen said.

But if scientists can figure out where the precancerous cells are, they can try to destroy them as well, he said.

Evers said the research could allow scientists to figure out which specific cells need to be targeted by drugs and allow doctors to monitor whether a treatment is working properly.

More information:

There's more on leukemia at The Leukemia & Lymphoma Society.



SOURCES: Tariq Enver, Ph.D., professor, MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, U.K.; Bart Kamen, M.D., Ph.D., chief medical officer, The Leukemia & Lymphoma Society, White Plains, N.Y.; Jan. 18, 2008, Science


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Gets Closer to Origins of Leukemia
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: